PT Kalbe Farma Tbk. (PTKFY)

PNK: PTKFY · Real-Time Price · USD

16.00

-2.41 (-13.09%)

At close: May 01, 2025, 3:30 PM

PT Kalbe Farma Tbk. Balance Sheet Statement

Financials in IDR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	4,723.3B	3,232.4B	3,949.8B	6,216.2B	5,207.9B	3,040.5B	3,153.3B	2,784.7B	2,895.6B
Short-Term Investments	143.14B	165.5B	145.31B	258.92B	188.32B	195.62B	178.72B	186.5B	179.33B
Long-Term Investments	374.48B	450.8B	239.24B	44.35B	-64.98B	-104.55B	-92.61B	-107.63B	-90.19B
Other Long-Term Assets	639.32B	843.97B	289.63B	358.42B	305.58B	353.28B	344.47B	316.52B	319.91B
Receivables	5,013.2B	4,652B	4,613.6B	3,431B	3,477.2B	3,572.9B	3,255.5B	2,876.4B	2,631.2B
Inventory	6,501.6B	6,792B	7,027.4B	5,087.3B	3,599.7B	3,738B	3,474.6B	3,557.5B	3,344.4B
Other Current Assets	77.76B	887.7B	831.03B	613.41B	421.71B	442.94B	395.54B	61.34B	457.39B
Total Current Assets	17,187.7B	15,917.7B	16,710.2B	15,712.2B	13,075.3B	11,222.5B	10,648.3B	10,044B	9,572.5B
Property-Plant & Equipment	8,756.2B	8,067B	8,346.6B	8,302B	8,469.1B	7,977.9B	6,650.7B	5,788B	4,863.3B
Goodwill & Intangibles	2,351.7B	1,778B	1,528.1B	1,157.8B	693.85B	692.45B	464.3B	419.57B	400.21B
Total Long-Term Assets	12,242.1B	11,139.8B	10,531.1B	9,954.4B	9,489B	9,042.2B	7,497.9B	6,572.3B	5,653.5B
Total Assets	29,429.7B	27,057.6B	27,241.3B	25,666.6B	22,564.3B	20,264.7B	18,146.2B	16,616.2B	15,226B
Account Payables	1,892.2B	1,690.7B	1,996.6B	1,667.6B	1,240.4B	1,215.9B	1,289.9B	1,108.6B	1,127.3B
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	188.12B	190.79B	1,000.6B
Short-Term Debt	322.11B	278.29B	829.3B	70B	344.34B	169.06B	96.26B	171.44B	147.39B
Other Current Liabilities	772.51B	717.79B	747.59B	784.36B	1,170.1B	553.98B	259.7B	346.21B	889.99B
Total Current Liabilities	4,185.7B	3,243.2B	4,431B	3,534.7B	3,176.7B	2,577.1B	2,286.2B	2,227.3B	2,317.2B
Long-Term Debt	194.98B	298.34B	287.03B	490.28B	722.82B	647.65B	259.83B	144.34B	132.24B
Other Long-Term Liabilities	370.42B	375.6B	368.55B	499.82M	320.35B	334.11B	13.72B	9.8B	9.8B
Total Long-Term Liabilities	653.54B	694.38B	712.95B	866.1B	1,111.5B	982.04B	565.44B	494.87B	445B
Total Liabilities	4,839.3B	3,937.5B	5,144B	4,400.8B	4,288.2B	3,559.1B	2,851.6B	2,722.2B	2,762.2B
Total Debt	559.22B	618.54B	1,167.7B	626.16B	1,157.8B	816.85B	357.41B	318.99B	283.11B
Common Stock	468.75B	468.75B	468.75B	468.75B	468.75B	468.75B	468.75B	468.75B	468.75B
Retained Earnings	22,941.8B	21,506.8B	20,187.5B	18,468.5B	16,624.6B	15,135.2B	13,871.7B	12,610.5B	11,261.1B
Comprehensive Income	n/a	447.31B	767.02B	678.47B	348.32B	323.33B	317.11B	192.89B	213.48B
Shareholders Equity	22,788.9B	21,418.9B	20,385.2B	19,579.5B	17,405.5B	15,893.1B	14,623.5B	13,280.8B	11,909.3B
Total Investments	517.62B	616.29B	384.54B	303.27B	123.34B	91.06B	86.11B	78.86B	89.13B